ATAI vs IDXX · rev $4.1M vs P/E 40, rev $2.36B
ATAI Life Sciences BV (ATAI) versus IDEXX Laboratories Inc (IDXX) — a side-by-side from cached financials, not a winner call.
ATAI Life Sciences BV (ATAI) is a biotechnology company listed on US.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Latest reported ATAI revenue for 2025-12-31 was $4.1M. Net income was -$660.0M. Revenue was up 1227.6% from 2024-12-31 to 2025-12-31. ATAI currently screens at market cap $555.8M.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
ATAI currently screens at market cap $555.8M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Not investment advice. Open the ATAI and IDXX stock pages for the full models.
Not investment advice.